Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes
塞拉托格雷（一种新型 P2Y12 受体拮抗剂）单剂量皮下注射治疗慢性冠状动脉综合征患者的药效学、药代动力学和安全性研究
期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehz807
Storey, Robert F; Gurbel, Paul A; Ten Berg, Jurrien; Bernaud, Corine; Dangas, George D; Frenoux, Jean-Marie; Gorog, Diana A; Hmissi, Abdel; Kunadian, Vijay; James, Stefan K; Tanguay, Jean-Francois; Tran, Henry; Trenk, Dietmar; Ufer, Mike; Van der Harst, Pim; Van't Hof, Arnoud W J; Angiolillo, Dominick J
